Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Department of Pediatrics, Weill Cornell Medicine, New York City, New York.
J Biopharm Stat. 2021 Sep 3;31(5):634-649. doi: 10.1080/10543406.2021.1931271. Epub 2021 Jun 7.
Newer immunoassay platforms offer improved signal-to-noise ratio but are more expensive. Thus, it is more cost efficient to perform these assays at a few selected, rather than a full series of, sample dilutions. We propose a new four-parameter paired response curve to model the relationship between assay outcomes from two sample dilutions and study likelihood-based inference. Given a fitted paired response curve, we can predict assay outcomes for de novo dilutions of samples, which enables cross-protocol comparison of immune response biomarkers even when different protocols use different sample dilutions. Numerical studies on both simulated and real data are presented.
新型免疫分析平台提供了更高的信噪比,但价格也更昂贵。因此,在少数几个经过精选的样本稀释度而非全系列样本稀释度上进行这些检测更具成本效益。我们提出了一种新的四参数配对响应曲线,用于模拟两种样本稀释度的检测结果之间的关系,并研究基于似然的推断。给定拟合的配对响应曲线,我们可以预测新的样本稀释度的检测结果,从而即使不同的方案使用不同的样本稀释度,也能实现免疫反应生物标志物的跨方案比较。本文还对模拟数据和真实数据进行了数值研究。